These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17252538)

  • 41. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer.
    Abdul M; Mccray SD; Hoosein NM
    Acta Oncol; 2008; 47(8):1546-50. PubMed ID: 18607852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin E suppresses telomerase activity in ovarian cancer cells.
    Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
    Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
    J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
    Heisler T; Towfigh S; Simon N; Liu C; McFadden DW
    J Surg Res; 2000 Jan; 88(1):23-5. PubMed ID: 10644462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
    Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
    BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rap2 regulates androgen sensitivity in human prostate cancer cells.
    Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
    Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin E succinate decreases lung cancer tumor growth in mice.
    Quin J; Engle D; Litwiller A; Peralta E; Grasch A; Boley T; Hazelrigg S
    J Surg Res; 2005 Aug; 127(2):139-43. PubMed ID: 16083751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells.
    Qian M; Kralova J; Yu W; Bose HR; Dvorak M; Sanders BG; Kline K
    Oncogene; 1997 Jul; 15(2):223-30. PubMed ID: 9244357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thapsigargin resistance in human prostate cancer cells.
    O'Neill JP; Velalar CN; Lee DI; Zhang B; Nakanishi T; Tang Y; Selaru F; Ross D; Meltzer SJ; Hussain A
    Cancer; 2006 Aug; 107(3):649-59. PubMed ID: 16770788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines.
    Haddad AQ; Venkateswaran V; Viswanathan L; Teahan SJ; Fleshner NE; Klotz LH
    Prostate Cancer Prostatic Dis; 2006; 9(1):68-76. PubMed ID: 16314891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-tocopherol succinate inhibits growth of gastric cancer cells in vitro.
    Rose AT; McFadden DW
    J Surg Res; 2001 Jan; 95(1):19-22. PubMed ID: 11120630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of gene expression by alpha-tocopherol.
    Azzi A; Gysin R; Kempná P; Munteanu A; Villacorta L; Visarius T; Zingg JM
    Biol Chem; 2004 Jul; 385(7):585-91. PubMed ID: 15318806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of vitamin E transport.
    Stocker A
    Ann N Y Acad Sci; 2004 Dec; 1031():44-59. PubMed ID: 15753133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.